摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl 4-methylbenzenesulfonate | 65338-95-6

中文名称
——
中文别名
——
英文名称
2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl 4-methylbenzenesulfonate
英文别名
2-(tetrahydro-2H-pyran-2-yloxy)ethyl 4-methylbenzenesulfonate;2-(oxan-2-yloxy)ethyl 4-methylbenzenesulfonate
2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl 4-methylbenzenesulfonate化学式
CAS
65338-95-6
化学式
C14H20O5S
mdl
——
分子量
300.376
InChiKey
WHFUIVZZHQPGTF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    447.3±45.0 °C(Predicted)
  • 密度:
    1.24±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    70.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-((tetrahydro-2H-pyran-2-yl)oxy)ethyl 4-methylbenzenesulfonate 在 palladium on activated charcoal 氢气 、 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 60.0h, 生成 (-)-(1R,2S,3R,4S)-2-(2-tetrahydropyranyloxy)ethoxy-3-(2-benzyloxy)ethoxy-1,7,7-trimethylbicyclo<2.2.1>heptane
    参考文献:
    名称:
    Sasaki, Shigeki; Kawasaki, Motoji; Koga, Kenji, Chemical and pharmaceutical bulletin, 1985, vol. 33, # 10, p. 4247 - 4266
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Synthesis of chiral diaza-18-crown-6 derivatives from optically active diethanolamines
    摘要:
    Homotopic 1,10-diaza-18-crown-6 derivatives with two, four, and six chiral centers have been prepared in optically active form from diethanolamines via a cyclization reaction with tosylates 39 and 48. The requisite optically active diethanolamines were prepared from chiral cyanohydrins and chiral ethanolamines by a one-pot Grignard-transimination-reduction or a one-pot reduction-transimination-reduction procedure. Yields were strongly affected by the size of the substituents alpha to the nitrogen atom. The stereoselectivity of the diethanolamine synthesis was found to depend on the configuration of the ethanolamine used.
    DOI:
    10.1021/jo00068a029
点击查看最新优质反应信息

文献信息

  • [5,6]HETEROCYCLIC COMPOUND
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP2565185A1
    公开(公告)日:2013-03-06
    Abstract: An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula (I) or a pharmacologically acceptable salt thereof. In the general formula (I), R1 and R2 represent hydrogen atoms, and the like; R3 represents a hydrogen atom, and the like; X, Y, and Z represent nitrogen atoms, and the like; A represents a phenylene group, and the like; n represents 1 or 2, and the like; and V and W represent oxygen atoms, and the like.
    摘要:本发明的目的是提供一种表现出促进骨生成作用的新型低分子量化合物。该目的通过具有通式(I)或其药理学可接受的盐的化合物实现。在通式(I)中,R1和R2代表氢原子等;R3代表氢原子等;X、Y和Z代表氮原子等;A代表苯基等;n代表1或2等;V和W代表氧原子等。
  • Synthesis and extraction properties of some lariat ethers derived from the spontaneously resolved guaifenesin, 3-(2-methoxyphenoxy)propane-1,2-diol
    作者:Zemfira A. Bredikhina、Rimma M. Eliseenkova、Robert R. Fayzullin、Viktorina G. Novikova、Sergey V. Kharlamov、Dilyara R. Sharafutdinova、Shamil K. Latypov、Alexander A. Bredikhin
    DOI:10.3998/ark.5550190.0012.a02
    日期:——
    Capable of spontaneous resolution rac-3-(2-methoxyphenoxy)propane-1,2-diol, guaifenesin 1 has been proposed as a cheap and readily available enantiopure precursor for the synthesis of nonracemic crown ethers having ligating OAr and OMe arms (lariat ethers). The crowns studied failed to form stable host/guest complexes with amine hydrochloride salts; the effective complexation was achieved using hexafluorophosphate
    能够自发拆分外消旋-3-(2-甲氧基苯氧基)丙烷-1,2-二醇,愈创甘油醚 1 已被提议作为一种廉价且容易获得的对映体纯前体,用于合成具有结扎 OAr 和 OMe 臂的非外消旋冠醚(套索醚) )。研究的牙冠未能与胺盐酸盐形成稳定的宿主/客体复合物;使用六氟磷酸盐实现了有效的络合。套索醚11c 实现了R*NH2·HPF6 的适度对映体识别。总的来说,提取的对映选择性与套索醚的提取能力成反比。
  • COMPOUND SUITABLE FOR DETECTION OF MITOCHONDRIAL COMPLEX-1
    申请人:HAMAMATSU PHOTONICS K.K.
    公开号:US20150225368A1
    公开(公告)日:2015-08-13
    Provided is a compound represented by formula (1-0): wherein in formula (1-0), R represents —O(CH 2 ) n —, —O(CH 2 ) n OC 2 H 4 —, —CH 2 O(CH 2 ) n — or —CH 2 O(CH 2 ) n OC 2 H 4 —; n represents an integer from 1 to 5; and Q 1 represents F or —OCH 3 .
    提供的化合物的化学式为(1-0):其中在化学式(1-0)中,R代表—O(CH2)n—,—O(CH2)nOC2H4—,—CH2O(CH2)n—或—CH2O(CH2)nOC2H4—;n代表1到5之间的整数;Q1代表F或—OCH3。
  • DIAGNOSTIC AGENT FOR THERAPEUTIC EFFECT ON CANCER
    申请人:HAMAMATSU PHOTONICS K.K.
    公开号:US20160256578A1
    公开(公告)日:2016-09-08
    The present invention provides a diagnostic agent for a therapeutic effect on cancer, containing a compound represented by formula (1-0). (In formula (1-0), R represents —O(CH 2 ) n —, —O(CH 2 ) n OC 2 H 4 —, —CH 2 O(CH 2 ) n —, or —CH 2 O(CH 2 ) n OC 2 H 4 —, n represents an integer of 1 to 5, and Q 1 represents F or —OCH 3 .)
    本发明提供了一种用于治疗癌症的诊断试剂,包含由式(1-0)表示的化合物。(在式(1-0)中,R代表—O(CH2)n—,—O(CH2)nOC2H4—,—CH2O(CH2)n—或—CH2O(CH2)nOC2H4—,n代表1至5的整数,Q1代表F或—OCH3。)
  • Facile Preparation of Optically Active Bicyclo[3.3.1]nonane-2,6-diol and 3,3,7,7-Tetramethylbicyclo[3.3.1]nonane-2,6-diol by Enzyme-Catalyzed Hydrolysis, and Enantiomer Recognition Behavior of Crown Ethers and Podands Having These Diols as a Chiral Subunit
    作者:Koichiro Naemura、Takahisa Matsumura、Masanori Komatsu、Yoshiki Hirose、Hiroaki Chikamatsu
    DOI:10.1246/bcsj.62.3523
    日期:1989.11
    with 86% e.e. By lithium aluminum hydride reduction, (+)-4 and (−)-5 were converted to (+)-bicyclo[3.3.1]nonane-2,6-diol (3) and (−)-3 with high optical purity, respectively, and (+)-7 was obtained from (+)-9. Using these optically active diols 3 and 7 as a chiral subunit, optically active crown ethers and podands were prepared and their enantiomer recognition behavior was evaluated by the enantiomer
    使用来自圆柱假丝酵母的脂肪酶水解 2,6-二乙酰氧基双环 [3.3.1] 壬烷 (5) 得到 (+)-(1S,2R,5S,6R)-6-乙酰氧基双环 [3.3.1]nonan-2-ol ( 4) 具有 81% ee 和 (-)-(1R,2S,5R,6S)-5 具有 95% ee,以及猪肝酯酶催化的 2,6-二乙酰氧基-3,3,7,7-四甲基双环水解[3.3.1]壬烷 (9) 得到 (-)-(1S,2R,5S,6R)-3,3,7,7-四甲基双环 [3.3.1] 壬烷-2,6-二醇 (7),其中 96 %ee和(+)-(1R,2S,5R,6S)-9与86%ee 通过氢化铝锂还原,(+)-4和(-)-5转化为(+)-双环[3.3。 1]壬烷-2,6-二醇 (3) 和 (-)-3 分别具有高光学纯度,(+)-7 由 (+)-9 获得。使用这些光学活性二醇 3 和 7 作为手性亚基,
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐